Gain Therapeutics Competitors and Similar CompaniesClear all
UCB's competitors and similar companies include Ipsen and CSL Behring.
 UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |||
Founding Date | Founding Date 1928 | Founding Date 1929 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 9,052 | Employees 5,358 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 34.3 b | Valuation ($) 10.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods €1.4b (FY, 2025) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €7.2b (FY, 2025) | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income €1.6b (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Countries | Countries 35 (FY, 2019) | Countries N/A | Countries 100 (Dec, 2020) |
For sources of this data, please see the company profile